Lipoid pneumonia historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Lipoid pneumonia}} {{CMG}}; {{AE}} ==Overview== ==Historical Perspective== ===Discovery=== * There is limited information about the historical perspective of [d...")
 
No edit summary
Line 8: Line 8:


===Discovery===
===Discovery===
* There is limited information about the historical perspective of [disease name].
OR
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].


*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe lipoid pneumonia .
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*He first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children.
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
*He described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates.


===Landmark Events in the Development of Treatment Strategies===
<br />
 
===Impact on Cultural History===
 
===Famous Cases===
The following are a few famous cases of [disease name]:


==References==
==References==

Revision as of 03:30, 27 September 2019

Lipoid pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lipoid pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lipoid pneumonia historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lipoid pneumonia historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lipoid pneumonia historical perspective

CDC on Lipoid pneumonia historical perspective

Lipoid pneumonia historical perspective in the news

Blogs on Lipoid pneumonia historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lipoid pneumonia historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • In 1925,G. F. LAUGHLEN, M.D. was the first physician to describe lipoid pneumonia .
  • He first interacted to the disease by routine autopsy at the Toronto, Ontorio hospital for sick children.
  • He described grayish red nodules at the autopsy with three types of exudates, found out mononuclear cells which were unexpected in the exudates.


References

Template:WH Template:WS